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Abstract The article describes paraganglioma case in
woman with von Hippel–Lindau disease. She was found to
be a carrier of a rare germline mutation in the VHL gene
(393C[A; N131K). The patient developed large, untypical
for von Hippel–Lindau disease, carotid body paragangli-
oma at the common carotid artery bifurcation. The carotid
body paraganglioma coexisted with the haemangioblas-
toma situated intramedullary in region C5/C6. The
haemangioblastoma reached the right-sided dorsal part of
the spinal cord in section C5/C6. It produced radicular
symptoms within C5/C6, followed by the later paresis of
the right limbs. The haemangioblastoma was resected
completely. Twelve months after the operation, the spinal
symptoms receded and the carotid body paraganglioma still
was asymptomatic. The current case of carotid body par-
aganglioma in patient with the 393C[A (N131K) missense
mutation in the VHL gene, supports association of this
speciﬁc mutation and VHL disease type 2, and suggests its
correlation with susceptibility to paragangliomas.
Keywords Von Hippel–Lindau disease  Carotid body
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Introduction
Von Hippel–Lindau disease is a syndrome of high genetic
predisposition towards neoplasms, which shows genea-
logical traits of autosomal dominant inheritance. The fre-
quency of occurrence of this condition is estimated at 1 per
36 thousand people, which means that in Poland there are
about 1,000 patients suffering from VHL disease. The
condition is caused by carrying germline mutations of the
VHL gene. The diagnosis of VHL disease is established
based on genealogical/clinical criteria and an analysis of
carrying mutations of the VHL gene. Families who are
affected by VHL undergo a series of preventive/diagnostic
tests and examinations whose aim is early detection and
treatment of neoplastic lesions [1]. Von Hippel–Lindau
disease often manifests itself with the following conditions:
haemangioblastoma cerebelli, angioma of the brain stem
and of the spinal cord, retinal angiomatosis, renal cysts,
pancreas cysts, pheochromocytoma or renal carcinoma [2].
Paragangliomas, especially those situated extrarenally,
occur very rarely in Von Hippel–Lindau disease [3–8].
They develop within the adrenal medulla, abdominal cav-
ity, chest and occasionally—in the head and the neck. Zak
and Lawson [9] quote almost 20 sites within the head and
the neck where paragangliomas may occur, not only in Von
Hippel–Lindau disease.
The paraganglioma in the head and the neck is con-
nected to the parasympathetic system, while in the adrenal
medulla—to the sympathetic system. In Von Hippel–Lin-
dau disease the adrenal medulla is the place where the
tumour of the pheochromocytoma type develops. Up to 5%
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endogenous catecholamine intoxication [10].
Paragangliomas producing catecholamine lead to
hypertensive crises and are thought to be the cause of
various clinical symptoms of sudden onset.
Since paragangliomas of the neck occur very rarely in
Von Hippel–Lindau disease, we decided to discuss the case
of a patient with a lesion of this type on the neck and an
haemangioblastoma of the spinal cord. The latter was
treated surgically in the Department. No record has been
found in Poland of a patient with Von Hippel–Lindau
disease and a paraganglioma of the neck.
Case report
The female patient, aged 49, reported pains in her second
and third ﬁnger of the right hand that she had had for
2 years. Initial diagnosis revealed isthmus carpalis and the
patient was operated on without much success—no
improvement was noticed.
A year later, intensifying root pains of Root C5 and C6
on the right side were the reason for performing an MRI
scan of the cervical spine. The ﬁndings from the study
showed an intramedullary lesion of 1.5 cm in diameter,
localized at the height of C5–C6 with accompanying syrinx
stretching from C3 to C7. The patient was consulted neu-
rosurgically several times, but refused to submit to a sur-
gical treatment. Gradually, the pains extended to the entire
forearm of the upper right limb, and numbness appeared of
both lower limbs. She met the clinical diagnostic criteria
for VHL disease [11]. Sequencing of the VHL gene
revealed the presence of the 393C[A (N131K) missense
mutation (Fig. 1)[ 12]. VHL disease was also diagnosed in
her relatives (shown in Fig. 2).
The patient was treated surgically several times at the
Ophthalmological Department because of gradual deteriora-
tionofvisioninthelefteye.Presently,thepatientclaimstobe
blindinthelefteye.Anophthalmologicalexaminationproved
the presence of a vast retinal angiomatosis of the left eye.
Moreover, a CT scan of the abdominal cavity showed
renal cysts.
In the clinical examination carried out on admission to
the Department of Neurosurgery the following conditions
were found: amaurosis oculi sinistri, paraesthesiae to
algetic stimuli in the medial part of the right forearm and
ﬁrst , second and third ﬁngers of the right arm increased
deep reﬂexes in the upper right limb along with decreased
muscle power of this limb, as well as Babin ´ski syndrome
on the right side; RR: 134/85 mmHg; pulse: 76/min.
Fig. 1 Sequencing chromatogram showing the 393C[A (N131K) germline mutation in the VHL gene. The mutation is marked by an arrow
492 Neurol Sci (2011) 32:491–496
123An MRI scan of the cervical spine showed a contrast
enhancing image of an intramedullary lesion located near
C5/C6 and extending to the dorsal part of the spinal cord on
the right side to the subarachnoid space. Upwards to C3
and downwards to C7 syrinx was identiﬁed. An MRI of the
head demonstrated an angioma of 1.5 cm in diameter,
localized in the choroid ﬁssure on the right side with a
small cyst.
The patient was treated surgically. A laminectomy was
performed from C3 to C6. Then the spinal cord was incised
along the sulcus medianus posterior to uncover a lesion of
the type of haemangioblastoma and a syrinx ﬁlled with
yellow liquid. The neoplastic lesion was localized excen-
trically in the dorsal part of the spinal cord on its right side;
it reached the subarachnoid space and was connected to
Root C5 originating in the spinal cord. The tumour was
excised completely. In the postoperative course, some
paraesthesia and pains in the upper left limb appeared,
which gradually subsided within 3 weeks.
After the surgery, the upper right limb pain subsided and
the right-sided hemiparesis retreated. A follow-up MRI
showed a total resection of the tumour.
Below we present an MRI image of the cervical spine
before and after the surgery (Fig. 3a, b).
Findings from a histopathological test showed
haemangioblastoma.
At a follow-up examination estimating how complete
the excision had been, a tumour was discerned at the
common carotid artery bifurcation on the right side. As a
result, a detailed examination of the patient was made at
Fig. 3 a MR of the cervical
spine, sagital section:
intramedullary tumour at the
height of C5/C6 with syrinx
reaching as far as C3 and below
the lesion to C7. b MR of the
cervical spine, sagital section:
total resection of the tumour; a
considerable reduction of the
syrinx around the tumour
Fig. 2 Pedigree of family with VHL disease caused by the N131K
mutation. Solid squares indicate affected men, solid circles indicate
affected females. The type of cancer and age of diagnosis are
indicated next to the symbol.Aplus near the symbol indicates the
presence of the mutation. A minus near the symbol indicates mutation
negative cases. r hbl retinal haemangioblastoma, CNS hbl central
nervous system haemangioblastoma, d48 age of death, 49 current age
of a patient
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Cancer Centre in Gliwice.
The radiological examination showed a carotid body
paraganglioma of 45 9 32 9 24 mm
3 on the right side
(Fig. 4a, b)
The tumour can be seen in the right carotid space, in the
right common carotid artery (CCA) bifurcation into the
internal carotid artery (ICA) and the external carotid artery.
Thetumourappears hypointense inunenhancedT1-weighted
images. ‘‘Salt and pepper’’ signal pattern of the tumour is
visible in T2-weighted images.
The tumour appears fast and intense after contrast
enhancement.
Time signal intensive curves calculated from the
tumour, CCA, ICA appear to be of the same shape, max-
imum value of the signal intensity and maximum contrast
enhancement at the same time. These signs evidence the
heavy vascularization of the tumour. There are irregular
no-signal spots in T2 in the lesion, which may be consistent
with haemosiderin. The tumour models and translocates
outwards the neighbouring vascular structures without
inﬁltrating them; it models the parapharyngeal space and
the right-sided wall of the pharynx, as well as to some
extent the pterygeal muscles. The upper pole of the tumour
is adjacent to the cranial basis near the carotid canal inlet,
without traces of inﬁltration. The posterior part of the
tumour leans against the I and II vertebra arches on the
space of about 1.5 cm, without traces of inﬁltration. No
traces of inﬁltrating the intervertebral foramen were found.
The lower pole of the tumour is located about 2 cm above
the division of the common carotid artery. The tumour had
not given any symptoms until then. The patient refused to
agree to the treatment of the carotid body paraganglioma.
Laboratory testing of the noradrenaline level, adrenaline
in blood and HVA in the 24-h urine collection failed
to give evidence of catecholamine production by the
paraganglioma.
Three weeks after the surgery of the haemangioblastoma
of the spinal cord the patient was discharged from hospital
in good overall condition.
Discussion
Herein we describe a rare case of carotid body paragan-
glioma in a woman with von Hippel–Lindau disease,
caused by the N131K mutation in the VHL gene. The
N131K is a rare missense mutation of the VHL gene. To
date, it has been reported only once, in a family affected
with VHL type 2 disease (VHL with pheochromocytoma)
[13]. VHL type 2 disease is typically caused by missense
mutations. However, only speciﬁc missense mutations are
associated with pheochromocytoma—those mutations
which map to protein binding sites of pVHL and which are
predicted to cause local protein defects. The current case
report of carotid body paraganglioma in patient with the
393C[A (N131K) missense mutation, further supports asso-
ciationofthis mutationandVHLdiseasetype2,andsuggests
its correlation with susceptibility to tumours situated extrar-
enally. VHL kindreds with pheochromocytoma-associated
Fig. 4 a MR of the neck, frontal section: tumour in the carotid bifurcation, of the type of paraganglioma, on the right side. b MR of the neck,
axial section: tumour in the parapharyngeal space on the right side, of the type of paraganglioma
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chromocytoma as this is frequently the ﬁrst manifestation.
Therefore, the correlation between the 393C[A (N131K)
missense mutation and VHL type 2 may be useful in
genetic counselling.
On admission to the hospital, the patient could not see in
her left eye because of retinal angiomatosis; she suffered
from renal cysts, haemangioblastoma near the ﬁssura
chorioidea on the right side and she had symptoms of a
tumour of spinal cord. The retinal angioma found in the
patient occurs in over 50% of VHL patients, often leading
to blindness in the eye unless treated with laser therapy
or cryocoagulation, preferably in the asymptomatic
period [2].
The patient was referred to the Department of Neuro-
surgery because of the intramedullary tumour at C5/C6.
The lesion caused pain in the upper right limb and a slight
paresis of both right limbs. Pain is reported to be the most
frequent symptom of haemangioblastoma of the spinal cord
[14]. During the operation, it was discovered that the
tumour reached the subarachnoid space of the dorsal sur-
face of the spinal cord, and was connected to Root C5 on
the right side, which may have been the reason for pains
in the upper right limb. The fact that intramedullary
haemangioblastomas in von Hippel–Lindau disease usu-
ally reach the dorsal surface of the medulla/spinal cord
has already been reported by other authors [2, 15, 16].
The haemangioblastoma was accompanied by the syrinx
much larger in size than the tumour itself, which might
have been responsible for the numbness of the lower
l i m b s .A c c o r d i n gt oW a n e b oe ta l .[ 17], the symptoms of
VHL disease with haemangioblastoma of the spinal cord
are most often caused by the syrinx and not by the tumour
itself.
The tumour was not large in size—just 1.5 cm. Haem-
angioblastomas of the spinal cord, both the ones occurring
sporadically and the ones accompanying VHL disease, are
usually of small size, and the prognosis in the case of
surgical treatment is favourable [15, 18]. The tumour was
resected totally. After a total resection of heamangioblas-
toma in VHL patients, the recurrence in the same area is
extremely rare [2]. One cannot exclude, however, the
possibility of developing new angiomas in new locations.
A histopathological examination conﬁrmed the diagnosis
of haemangioblastoma. A tumour of this type usually
accompanies VHL disease [16].
In von Hippel–Lindau disease, a tumour of the medullar
layer of the adrenal gland of the pheochromocytoma type
occurs in 10–35% of cases [4, 10]. Lesions of the type of
paraganglioma, localized extrarenally, are extremely rare
[4–6, 19]. In the patient, a large lesion was found to orig-
inate in the carotid body and situated at the carotid bifur-
cation, on the right side. According to the radiological
ﬁndings, the tumour compressed the wall of the pharynx
and it displaced the neighbouring vascular structures out-
wards giving no clinical symptoms. The tumour is hor-
monally inactive; it was not joined to the cervical roots and
it did not inﬁltrate the intervertebral foramen. In view of
the absence of ailment, the patient currently refuses to
submit to surgical treatment of the paraganglioma.
Oosterwijk et al. [20] report that the frequency of
occurrence of surgically treated paragangliomas of the
head and the neck in The Netherlands comes to one case
per one million inhabitants annually. In the autopsy
material, paragangliomas of the neck occur much more
frequently [21, 22]. Therefore, a conclusion can be drawn
that paragangliomas of the head and the neck fail to pro-
duce clinical symptoms and consequently they are not
treated surgically. This is reﬂected in the case of the
patient.
Unlike the paragangliomas of the adrenal medulla, the
paragangliomas of the head and the neck usually do not
show endocrinal function [3]. The case of the patient seems
to conﬁrm this observation. That is why the paraganglio-
mas growing in the neck develop slowly, giving no clinical
symptoms for a long time [3]. Incidentally, these tumours
may metastasize to lungs [13].
Conclusion
The current case of carotid body paraganglioma in patient
with the 393C[A (N131K) missense mutation in the
VHL gene, supports association of this speciﬁc mutation
with VHL disease type 2, and suggests its correlation
with susceptibility to paragangliomas. VHL kindreds with
pheochromocytoma-associated missense mutations require
careful surveillance for pheochromocytoma as this is fre-
quently the ﬁrst manifestation. Therefore, a correlation
between the 393C[A (N131K) missense mutation and
VHL type 2 may be useful in genetic counselling.
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